wilson disease

56
Children with difficulty in speech and writing associated with pallor and abnormal liver function tests and seizures

Upload: saad-alani

Post on 12-May-2015

1.032 views

Category:

Health & Medicine


0 download

DESCRIPTION

Definition of Wilson disease ,presentation ,diagnosis ,treatment ,prognosis

TRANSCRIPT

Page 1: Wilson disease

Children with difficulty in speech and writing associated with pallor and abnormal liver

function tests and seizures

Page 2: Wilson disease

04/12/2023 Prof. Dr. Saad S Al Ani 2

13yr old boy history

• Difficulty in speech and writing for 4 years and also on walking for 1 year.• Difficulty to perform any work by

hands for 6 months• His speech was low volume slurred

and monotonous

Page 3: Wilson disease

04/12/2023 Prof. Dr. Saad S Al Ani 3

Examination

• Splenomegaly and bilateral gynaecomastia.• Muscle tone was mildly increased, and gait

was limping.• Slit lamp examination of eye revealed

bilateral Kayser-Fleischer ring with normal visual acuity.

Page 4: Wilson disease

04/12/2023 Prof. Dr. Saad S Al Ani 4

MRI T2 & T1-Weighted Image

Hyperintensity & Hypointensity in Bilateral Basal Ganglia & Putamen Region

Page 5: Wilson disease

04/12/2023 Prof. Dr. Saad S Al Ani 5

Normal MRI of the brain

Axial MRI image through the basal ganglia. Included in the basal ganglia are the caudate and putamen, globus pallidus externus (GPe), and globus pallidus internus (GPi). 

Page 6: Wilson disease

04/12/2023 Prof. Dr. Saad S Al Ani 6

11yr old boy history

• Progress pallor , lassitude ,mildly jaundice for the last 2 months

• Dysarthria• Salivation

Page 7: Wilson disease

04/12/2023 Prof. Dr. Saad S Al Ani 7

Examination

• Pallor , Jaundiced ,palmer erythema• Hepatomegaly• Postural tremor, dysdiadochokinesia• Dysarthria, Gait disturbances• The Kayser-Fleischer ring is found on

slit lamp examination of the eye

Page 8: Wilson disease

04/12/2023 Prof. Dr. Saad S Al Ani 8

Kayser-Fleischer ring

Page 9: Wilson disease

04/12/2023 Prof. Dr. Saad S Al Ani 9

Laboratory investigations

• Low serum albumin(26 gram/L)• Increased alanine transaminase

( A.L.T=57 U/L)

Page 10: Wilson disease

04/12/2023 Prof. Dr. Saad S Al Ani 10

Ultrasonogram

Hepatobiliary system revealed coarse hepatic tissue echotexture with splenomegaly.

Page 11: Wilson disease

04/12/2023 Prof. Dr. Saad S Al Ani 11

Liver scan

Slightly :• Nonuniform radiotracer distribution in

the liver • Increased bony uptake.

Page 12: Wilson disease

04/12/2023 Prof. Dr. Saad S Al Ani 12

Additional laboratory investigations

• Serum caeruloplasmin level was 11.51 mg/dl.

• 24 hours urinary copper excretion was 150 microgram per day

Page 13: Wilson disease

04/12/2023 Prof. Dr. Saad S Al Ani 13

17 years old boy history

• History of seizures for last 7 days• Generalized tonic clonic in nature.• For last 2 days he was having multiple

seizure episodes without regaining of consciousness in between.

Page 14: Wilson disease

04/12/2023 Prof. Dr. Saad S Al Ani 14

Prior history

• Behavioral disturbances in the form of :

- Disinterest in the surroundings

- Decreased interaction with friends

and relatives

- Occasional outburst of temper for last

4 months was present

Page 15: Wilson disease

04/12/2023 Prof. Dr. Saad S Al Ani 15

• Speech and gait difficulties for last 2 months.

• There was no history of headache, vomiting, visual disturbances or focal deficits.

• None of his siblings had similar illness.

Cont.

Page 16: Wilson disease

04/12/2023 Prof. Dr. Saad S Al Ani 16

• Vitals were stable • No jaundice or flaps• Abdominal examination did not reveal

organomegaly or free fluid.• On general examination Kayser-Fleischer

rings were present in cornea

General examination

Page 17: Wilson disease

04/12/2023 Prof. Dr. Saad S Al Ani 17

Neurological examination

• Mute, having mask like faces, drooling of saliva and dystonic tongue

• Generalized cogwheel rigidity in all 4 limbs including axial musculature

• Postural tremors of both upper limbs

Page 18: Wilson disease

04/12/2023 Prof. Dr. Saad S Al Ani 18

Cont.

• Hyperreflexia, extensor planters and

normal muscle strength. • Sensory and cerebellar system

examination was unremarkable• Ophthalmological exam showed Kayser-

Fleischer ring on slit lamp

Page 19: Wilson disease

04/12/2023 Prof. Dr. Saad S Al Ani 19

Diagnosis?

Page 20: Wilson disease

Wilson disease(Hepatolenticular Degeneration)

Prof. Dr. Saad S Al Ani

Senior Pediatric Consultant

Head of Pediatric Department

Khorfakkan hospital

Sharjah ,[email protected]

Page 21: Wilson disease

04/12/2023 Wilson Disease Prof. Dr. Saad S Al Ani 21

Wilson disease (Hepatolenticular degeneration)

Is an autosomal recessive disorder characterized by:

1.Degenerative changes in the brain

2. Liver disease

3.Kayser-Fleischer rings in the cornea

Page 22: Wilson disease

04/12/2023 Wilson Disease Prof. Dr. Saad S Al Ani 22

Autosomal recessive inborn error of copper transport

Page 23: Wilson disease

04/12/2023 Wilson Disease Prof. Dr. Saad S Al Ani 23

1/50,000-100,000 births

The incidence

Page 24: Wilson disease

04/12/2023 Wilson Disease Prof. Dr. Saad S Al Ani 24

Introduction

• The abnormal gene for Wilson disease is on chromosome 13; linkage studies have assigned the Wilson disease locus to chromosome 13 at q14-q21.

• The gene encodes amino acid structural motifs consistent with a role in copper-binding, cation-transporting P-type ATPase .

Page 25: Wilson disease

04/12/2023 Wilson Disease Prof. Dr. Saad S Al Ani 25

Basic mechanism

• Relates to decreased excretion of biliary copper, owing partly to a lysosomal defect of the liver cells

Page 26: Wilson disease

04/12/2023 Wilson Disease Prof. Dr. Saad S Al Ani 26

Healthy subjects: intake and excretion is well balanced

Page 27: Wilson disease

04/12/2023 Wilson Disease Prof. Dr. Saad S Al Ani 27

Normal absorption and distribution of copper

Cu = copper, CP = ceruloplasmin, green = ATP7B carrying copper.

Page 28: Wilson disease

04/12/2023 Wilson Disease Prof. Dr. Saad S Al Ani 28

Pathogenesis

Defective mobilization of copper

from lysosomes in liver cells

Relentless accumulation of copper in the liver

Copper then escapes the liver to damage other organs

Oxidant injury to hepatocyte mitochondria

Lipid peroxidation of the mitochondria

↓↓

Page 29: Wilson disease

04/12/2023 Wilson Disease Prof. Dr. Saad S Al Ani 29

Clinical Manifestations Forms of hepatic disease:

• Include :

1.Asymptomatic hepatomegaly

(with or without splenomegaly)

2.Subacute or chronic hepatitis

3.Fulminant hepatic failure.

Page 30: Wilson disease

04/12/2023 Wilson Disease Prof. Dr. Saad S Al Ani 30

Cont.

Other manifestations of Wilson disease include:

* Cryptogenic cirrhosis

* Portal hypertension,

* Ascites

* Edema,

* Variceal bleeding

Page 31: Wilson disease

04/12/2023 Wilson Disease Prof. Dr. Saad S Al Ani 31

Cont.

*Other effects of hepatic dysfunction :

- Delayed puberty

- Amenorrhea,

- Coagulation defect

Page 32: Wilson disease

04/12/2023 Wilson Disease Prof. Dr. Saad S Al Ani 32

Clinical Manifestations Neurologic and psychiatric disorders

• Intention tremor• Dysarthria• Dystonia• Deterioration in school performance, or

behavioral changes.

Page 33: Wilson disease

04/12/2023 Wilson Disease Prof. Dr. Saad S Al Ani 33

• Hemolysis may be an initial manifestation• Manifestations of Fanconi syndrome and

progressive renal failure• Unusual manifestations include:

- Arthritis

- Endocrinopathies, such as hypoparathyroidism

Clinical Manifestations other features

Page 34: Wilson disease

04/12/2023 Wilson Disease Prof. Dr. Saad S Al Ani 34

Diagnosis

Wilson disease should be considered in children and teenagers with :

1.Unexplained acute or chronic liver disease,

2. Neurologic symptoms of unknown cause,

3. Acute hemolysis

4.Psychiatric illnesses,

5. Behavioral changes,

6.Fanconi syndrome

7.Unexplained bone disease.

Page 35: Wilson disease

04/12/2023 Wilson Disease Prof. Dr. Saad S Al Ani 35

Tests performed for the diagnosis of Wilson disease

Page 36: Wilson disease

04/12/2023 Wilson Disease Prof. Dr. Saad S Al Ani 36

Cont.

• The best screening test is to measure the serum ceruloplasmin level.

Page 37: Wilson disease

04/12/2023 Wilson Disease Prof. Dr. Saad S Al Ani 37

• Serum copper level :

>100 μg /day and often up to 1,000 μg or more per day.

Cont.

Page 38: Wilson disease

04/12/2023 Wilson Disease Prof. Dr. Saad S Al Ani 38

• Is of value for :

1.Examination of the histology

2.Measurement of the hepatic copper

content (normally <10 μg/g dry weight).

Liver biopsy

Page 39: Wilson disease

04/12/2023 Wilson Disease Prof. Dr. Saad S Al Ani 39

Should include determination of :

1.Serum ceruloplasmin level

2. Urinary copper excretion.

Screening family members of patients

Page 40: Wilson disease

04/12/2023 Wilson Disease Prof. Dr. Saad S Al Ani 40

The first signs due to :

• Hepatic : (40% ) • Neurological : (35% ) • Psychiatric , Renal, Hematological ,

Endocrine ( In the remainder)

Page 41: Wilson disease

04/12/2023 Wilson Disease Prof. Dr. Saad S Al Ani 41

Wilson's disease patients before treatment: reduced excretion and retention

Page 42: Wilson disease

04/12/2023 Wilson Disease Prof. Dr. Saad S Al Ani 42

Treatment

Copper-chelating agents:• Oral administration of penicillamine (β, β-

dimethylcysteine) in a dose of :

* 0.5-0.75 g/day for patients younger than 10 yr.

*1 g/day in two doses before meals for adults

Page 43: Wilson disease

04/12/2023 Wilson Disease Prof. Dr. Saad S Al Ani 43

Wilson's disease patients on chelator therapy: enhanced urinary excretion of copper

Page 44: Wilson disease

04/12/2023 Wilson Disease Prof. Dr. Saad S Al Ani 44

Toxic effects of penicillamine

• Uncommon and consist of 1.Hypersensitivity reactions (Goodpasture

syndrome, systemic lupus erythematosus, polymyositis),

2. Interaction with collagen and elastin 3.Deficiency of other elements such as zinc 4.Aplastic anemia 5. Nephrosis

Page 45: Wilson disease

04/12/2023 Wilson Disease Prof. Dr. Saad S Al Ani 45

• For those patients who are unable to tolerate penicillamine, triethylene tetramine dihydrochloride (Trien, TETA, trientine) at a dose of 0.5-2 g/24 hr is an acceptable alternative.

Treatment (cont.)

Page 46: Wilson disease

04/12/2023 Wilson Disease Prof. Dr. Saad S Al Ani 46

• Zinc has also been used as adjuvant therapy or as maintenance therapy owing to its unique ability to impair the gastrointestinal absorption of copper.

• Zinc acetate is given in adults at a dose of 25 to 50 mg three times a day .

Treatment (cont.)

Page 47: Wilson disease

04/12/2023 Wilson Disease Prof. Dr. Saad S Al Ani 47

Wilson's disease patients on zinc therapy: enhanced fecal excretion of copper

Page 48: Wilson disease

04/12/2023 Wilson Disease Prof. Dr. Saad S Al Ani 48

Remember

• Foods such as:

liver, shellfish, nuts, and chocolate should be avoided

Page 49: Wilson disease

04/12/2023 Wilson Disease Prof. Dr. Saad S Al Ani 49

Prognosis

• Untreated patients with Wilson disease die of the hepatic, neurologic, renal, or hematologic complications.

Page 50: Wilson disease

04/12/2023 Wilson Disease Prof. Dr. Saad S Al Ani 50

Cont.

• The prognosis for patients receiving prompt and continuous d- penicillamine is variable and depends on :

* Time of initiation

* Individual responsiveness .

Page 51: Wilson disease

04/12/2023 Wilson Disease Prof. Dr. Saad S Al Ani 51

Liver transplantation

• Should be considered for patients with:

1. fulminant liver disease

2. decompensated cirrhosis

3. progressive neurologic disease

Page 52: Wilson disease

04/12/2023 Wilson Disease Prof. Dr. Saad S Al Ani 52

In asymptomatic siblings of affected patients

Early institution of chelation therapy can prevent expression of the disease.

Page 53: Wilson disease

04/12/2023 Wilson Disease Prof. Dr. Saad S Al Ani 53

Remember Wilson disease

1.If "routine liver function tests" are inexplicably abnormal in a child

2.In a child with haemolysis and negative Coombs test

3. Changes in mood or school performance in a teenager, especially with speech slurring

Page 54: Wilson disease

04/12/2023 Wilson Disease Prof. Dr. Saad S Al Ani 54

.

Page 55: Wilson disease

04/12/2023 Wilson Disease Prof. Dr. Saad S Al Ani 55

References

• http://www.eurowilson.com/en/living/guide/pathway/index.phtml

• http://www.wilsonsdisease.org/• http://www.ars.usda.gov/Services/docs.htm?do

cid=17477 

• http://emedicine.medscape.com/article/183456-clinical

• http://www.eurowilson.org/data/pdf/For-medical-professionals.pdf

Page 56: Wilson disease

04/12/2023 Wilson Disease Prof. Dr. Saad S Al Ani 56